Roslyn E. Wallace
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Prostate Cancer Treatment and Research
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Polyomavirus and related diseases 3
- Co-authors
- Frederick E. Durr (6 shared papers)K. C. Murdock (3 shared papers)Robert B. Angier (2 shared papers)P. F. FABIO (1 shared paper)Ralph G. Child (1 shared paper)R. V. Citarella (1 shared paper)John C. Petricciani (7 shared papers)Hope E. Hopps (2 shared papers)
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Nature (3 papers)The Lancet Oncology (3 papers)Experimental Cell Research (1 paper)Cancer Investigation (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Roslyn E. Wallace
23 papers receiving 964 citations
Roslyn E. Wallace's Hit Papers
Peers
Comparison fields: 5 of 80
- Toxicology 100
- Pulmonary and Respiratory Medicine 355
- Oncology 254
- Radiology, Nuclear Medicine and Imaging 196
- Cancer Research 84
Countries citing papers authored by Roslyn E. Wallace
This map shows the geographic impact of Roslyn E. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roslyn E. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roslyn E. Wallace more than expected).
Fields of papers citing papers by Roslyn E. Wallace
This network shows the impact of papers produced by Roslyn E. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roslyn E. Wallace. The network helps show where Roslyn E. Wallace may publish in the future.
Co-authors
The 23 scholars most cited alongside Roslyn E. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 259 | |
| 2 | PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial Hit paper breakdown → | 2022 | 205 |
| 3 | Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial Hit paper breakdown → | 2023 | 154 |
| 4 | Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. | 1979 | 137 |
| 5 | 1973 | 53 | |
| 6 | 1964 | 38 | |
| 7 | 1973 | 35 | |
| 8 | Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. | 1982 | 32 |
| 9 | 1971 | 31 | |
| 10 | 1987 | 19 | |
| 11 | 2025 | 18 | |
| 12 | 1984 | 17 | |
| 13 | A comparison of three in vivo assays for cell tumorigenicity. | 1974 | 14 |
| 14 | 1973 | 12 | |
| 15 | 1961 | 9 | |
| 16 | 1958 | 9 | |
| 17 | 1967 | 7 | |
| 18 | 1989 | 7 | |
| 19 | 1961 | 7 | |
| 20 | 1976 | 5 |
About Roslyn E. Wallace
Roslyn E. Wallace is a scholar working on Oncology, Immunology, Genetics, Pulmonary and Respiratory Medicine and Animal Science and Zoology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Polyomavirus and related diseases (3 papers), Animal Virus Infections Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Toxicology (100 citations), Pulmonary and Respiratory Medicine (355 citations), Oncology (254 citations), Radiology, Nuclear Medicine and Imaging (196 citations) and Cancer Research (84 citations). Roslyn E. Wallace has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Frederick E. Durr, K. C. Murdock, Robert B. Angier, P. F. FABIO, Ralph G. Child, R. V. Citarella, John C. Petricciani, Hope E. Hopps, Douglas E. Lorenz and Herald R. Cox. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Nature, The Lancet Oncology, Experimental Cell Research and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.